The role of inflammation in Alzheimer's disease

Abraham, 2001, Reactive astrocytes and α1-antichymotrypsin in Alzheimer's disease, Neurobiology of Aging, 22, 931, 10.1016/S0197-4580(01)00302-5 Abraham, 1988, Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease, Cell, 52, 487, 10.1016/0092-8674(88)90462-X Afagh, 1996, Localization and cell association of C1q in Alzheimer's disease brain, Experimental Neurology, 138, 22, 10.1006/exnr.1996.0043 Aisen, 2002, The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease, The Lancet Neurology, 1, 279, 10.1016/S1474-4422(02)00133-3 Aisen, 2000, A randomized controlled trial of prednisone in Alzheimer's disease: Alzheimer's disease cooperative study, Neurology, 54, 588, 10.1212/WNL.54.3.588 Aisen, 2003, Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression, Journal of the American Medical Association, 289, 2819, 10.1001/jama.289.21.2819 Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiology of Aging, 21, 383, 10.1016/S0197-4580(00)00124-X Akiyama, 2000, Cell mediators of inflammation in the Alzheimer disease brain, Alzheimer Disease and Associated Disorders, 14, S47, 10.1097/00002093-200000001-00008 Araque, 2002, Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices, The Journal of Neuroscience, 22, 2443, 10.1523/JNEUROSCI.22-07-02443.2002 Arias, 2000, Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors, Neurochemistry International, 36, 595, 10.1016/S0197-0186(99)00154-0 Arias, 2002, Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptor, International Review of Neurobiology, 54, 1, 10.1016/S0074-7742(03)54002-8 Arosio, 2004, Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease, Neurobiology of Aging, 25, 1009, 10.1016/j.neurobiolaging.2003.10.009 Auld, 2002, Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies, Progress in Neurobiology, 68, 209, 10.1016/S0301-0082(02)00079-5 Bard, 2000, Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease, Nature Medicine, 6, 916, 10.1038/78682 Bate, 2003, Neurons treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-β1–42, Neuroreport, 14, 2099, 10.1097/00001756-200311140-00018 Bergamaschini, 2001, Activation of complement and contact system in Alzheimer's disease, Mechanisms of Ageing and Development, 122, 1971, 10.1016/S0047-6374(01)00311-6 Bitting, 1996, Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide, The Journal of Biological Chemistry, 271, 16084, 10.1074/jbc.271.27.16084 Blasko, 1999, TNF alpha plus IFN gamma induce the production of Alzheimer beta-amyloid peptides, and decrease the secretion of APPs, FASEB Journal, 13, 63, 10.1096/fasebj.13.1.63 Blasko, 2001, Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells, Neurobiology of Disease, 8, 1094, 10.1006/nbdi.2001.0451 Borovikova, 2000, Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin, Nature, 405, 458, 10.1038/35013070 Bradt, 1998, Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide, Journal of Experimental Medicine, 188, 431, 10.1084/jem.188.3.431 Breitner, 1996, The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease, Annual Review of Medicine, 47, 401, 10.1146/annurev.med.47.1.401 Brejc, 2001, Crystal structure of an Ach-binding protein reveals the ligand-binding domain of nicotinic receptors, Nature, 411, 269, 10.1038/35077011 Chao, 1996, Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism, Glia, 16, 276, 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X Chen, 1996, Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches, Neurobiology of Aging, 17, 781, 10.1016/0197-4580(96)00103-0 Chesneau, 2000, Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization, The Biochemical Journal, 351, 509, 10.1042/0264-6021:3510509 Combs, 2000, Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists, Journal of Neuroscience, 20, 558, 10.1523/JNEUROSCI.20-02-00558.2000 Combs, 2001, Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferators-activated receptor α, Neurochemistry International, 39, 449, 10.1016/S0197-0186(01)00052-3 Culpan, 2003, Tumor necrosis factor-α gene polymorphism and Alzheimer's disease, Neuroscience Letters, 350, 61, 10.1016/S0304-3940(03)00854-1 Deeks, 2002, Efficacy, tolerability and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systemic review of randomized controlled trials, British Medical Journal, 325, 619, 10.1136/bmj.325.7365.619 Dickson, 1997, The pathogenesis of senile plaques, Journal of Neuropathology and Experimental Neurology, 56, 321, 10.1097/00005072-199704000-00001 Edbauer, 2002, Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD), Journal of Biological Chemistry, 277, 13389, 10.1074/jbc.M111571200 El Khoury, 1996, Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils, Nature, 382, 716, 10.1038/382716a0 Elward, 2003, “Eat me” and “don’t eat me” signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system, Molecular Immunology, 40, 85, 10.1016/S0161-5890(03)00109-3 Eriksen, 2003, NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo, The Journal of Clinical Investigation, 112, 440, 10.1172/JCI200318162 Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo, Proceedings of the National Academy of Sciences USA, 100, 4162, 10.1073/pnas.0230450100 Farris, 2004, Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein, American Journal of Pathology, 164, 1425, 10.1016/S0002-9440(10)63229-4 Feinstein, 2002, Noradrenergic regulation of inflammatory gene expression in brain, Neurochemistry International, 41, 357, 10.1016/S0197-0186(02)00049-9 Ferrari, 2000, Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia, Experimental Gerontology, 35, 1239, 10.1016/S0531-5565(00)00160-1 Fiala, 1998, Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model, Molecular Medicine, 4, 480, 10.1007/BF03401753 Fidani, 2002, Interleukin-1A is not associated with late onset Alzheimer's disease, Neuroscience Letters, 323, 81, 10.1016/S0304-3940(02)00114-3 Fillit, 1991, Elevated circulating TNF levels in Alzheimer's disease, Neuroscience Letters, 129, 318, 10.1016/0304-3940(91)90490-K Frackowiak, 1992, Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils, Acta Neuropathologica, 84, 225, 10.1007/BF00227813 Frautschy, 1992, Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer's beta-amyloid, American Journal of Pathology, 140, 1389 Friedman, 2001, Cytokines regulate expression of the Type 1 interleuken-1 receptor in rat hippocampal neurons and glia, Experimental Neurology, 168, 23, 10.1006/exnr.2000.7595 Galea, 2003, Intrinsic regulation of brain inflammatory responses, Cellular and Molecular Neurobiology, 23, 625, 10.1023/A:1025084415833 Gambassi, 1997, Steroid therapy in AD, Neurology, 48, 1473, 10.1212/WNL.48.5.1473 Graham, 2002, Immunohistochemical localization of nicotinic acetylcholine receptor subunits in human cerebellum, Neuroscience, 113, 493, 10.1016/S0306-4522(02)00223-3 Graham, 2003, Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus, Journal of Chemical Anatomy, 25, 97 Griffin, 1989, Brain interleukin I and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proceedings of the National Academy of Sciences USA, 86, 7611, 10.1073/pnas.86.19.7611 Griffin, 1995, Interleukin-1 expression in different plaque types in Alzheimer disease: significance in plaque evolution, Journal of Neuropathology and Experimental Neurology, 54, 276, 10.1097/00005072-199503000-00014 Griffin, 2000, The pervasiveness of interleukin-1 in Alzheimer's disease: a role for specific polymorphisms in disease risk, Experimental Gerontology, 35, 481, 10.1016/S0531-5565(00)00110-8 Grimaldi, 2000, Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism, Annals of Neurology, 47, 361, 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N Harris-White, 2001, Estrogen (E2) and glucocorticoid (Gc) effects on microglia and A beta clearance in vitro and in vivo, Neurochemistry International, 39, 435, 10.1016/S0197-0186(01)00051-1 Hedley, 2002, Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia, Annals of Neurology, 51, 797, 10.1002/ana.10196 Ho, 1999, Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease, Journal of Neuroscience Research, 57, 295, 10.1002/(SICI)1097-4547(19990801)57:3<295::AID-JNR1>3.0.CO;2-0 Hochstrate, 1995, Ca2+ influx into leech neuropile glial cells mediated by nicotinic acetylcholine receptors, Glia, 15, 43, 10.1002/glia.440150106 Hoozemans, 2003, Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease, Current Drug Targets, 4, 361, 10.2174/1389450033490902 Hopkins, 1995, Cytokines and the nervous system I: expression and recognition, Trends in Neuroscience, 18, 83, 10.1016/0166-2236(95)93881-W Hösli, 2000, Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: colocalization with cholinergic receptors, International Journal of Developmental Neuroscience, 18, 101, 10.1016/S0736-5748(99)00074-X Hösli, 2001, Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system, International Journal of Developmental Neuroscience, 19, 11, 10.1016/S0736-5748(00)00082-4 Hu, 1998, Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release, Brain Research, 785, 195, 10.1016/S0006-8993(97)01318-8 Hull, 2002, Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs, Current Medicinal Chemistry, 9, 83, 10.2174/0929867023371292 In’t Veld, 2001, Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease, New England Journal of Medicine, 345, 1515, 10.1056/NEJMoa010178 In’t Veld, 2002, Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence, Epidemiologic Reviews, 24, 248, 10.1093/epirev/mxf001 Jiang, 1994, Beta-Amyloid complement by binding to a specific region of the collagen-like domain of the C1q A chain, Journal of Immunology, 152, 5050, 10.4049/jimmunol.152.10.5050 Johnstone, 1999, A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced, Journal of Neuroimmunology, 93, 182, 10.1016/S0165-5728(98)00226-4 Kalaria, 1999, Microglia and Alzheimer's disease, Current Opinion in Heatology, 6, 15, 10.1097/00062752-199901000-00004 Kopek, 1998, Alzheimer's beta-amyloid peptide 1–42 induces a phagocytic response in murine microglia, Journal of Neurochemistry, 71, 2123, 10.1046/j.1471-4159.1998.71052123.x Kuo, 2003, Lack of association between interleukin-1α polymorphism and Alzheimer's disease, Alzheimer's Disease and Associated Disorders, 17, 94, 10.1097/00002093-200304000-00007 Kurt, 1999, B-amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study, Experimental Neurology, 158, 221, 10.1006/exnr.1999.7096 Landreth, 2001, Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease, Neurobiology of Aging, 22, 937, 10.1016/S0197-4580(01)00296-2 Lee, 2002, Cytokines, chemokines, and cytokine receptors in human microglia, Journal of Neuroscience Research, 69, 94, 10.1002/jnr.10253 Lehmann, 1997, Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs, Journal of Biological Chemistry, 272, 3406, 10.1074/jbc.272.6.3406 Li, 2000, Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex, Journal of Neurochemistry, 75, 1447, 10.1046/j.1471-4159.2000.0751447.x Li, 2000, S100β induction of the pro-inflammatory cytokine interleukin-6 in neurons: implications for Alzheimer pathogenesis, Journal of Neurochemistry, 74, 143, 10.1046/j.1471-4159.2000.0740143.x Liu, 1994, Tumor necrosis factor-alpha expression in ischemic neurons, Stroke, A Journal of Cerebral Circulation, 25, 1481, 10.1161/01.STR.25.7.1481 Lue, 2001, Involvement of microglial receptor for advanced glycation end products (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism, Experimental Neurology, 171, 29, 10.1006/exnr.2001.7732 Ma, 2004, Association between tumor necrosis factor-alpha promoter polymorphism in Alzheimer's disease, Neurology, 62, 307, 10.1212/01.WNL.0000103288.49441.E4 Mackenzie, 2001, Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation, Neurobiology of Aging, 22, 819, 10.1016/S0197-4580(01)00304-9 Mackenzie, 1998, Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging, Neurology, 50, 986, 10.1212/WNL.50.4.986 Mamdani, 2002, Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs, British Medical Journal, 325, 624, 10.1136/bmj.325.7365.624 Mahyar, 2003, Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies, British Medical Journal, 327, 128, 10.1136/bmj.327.7407.128 McGeer, 1995, The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Research Reviews, 21, 195, 10.1016/0165-0173(95)00011-9 McGeer, 2001, Inflammation, autotoxicity and Alzheimer disease, Neurobiology of Aging, 22, 799, 10.1016/S0197-4580(01)00289-5 McGeer, 1990, Anti-inflammatory drugs and Alzheimer's disease, Lancet, 335, 1037, 10.1016/0140-6736(90)91101-F McGeer, 1996, Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies, Neurology, 47, 425, 10.1212/WNL.47.2.425 McGeer, 2001, The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases, Neurobiology of Aging, 22, 843, 10.1016/S0197-4580(01)00288-3 Mitrasinovic, 2003, Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Aβ, Neurobiology of Aging, 24, 807, 10.1016/S0197-4580(02)00237-3 Mold, 1999, Regulation of complement activation by C-reactive protein, Immunopharmacology, 42, 23, 10.1016/S0162-3109(99)00007-7 Moore, 2002, Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease, Advanced Drug Delivery Reviews, 54, 1627, 10.1016/S0169-409X(02)00162-X Morita, 2002, Distinct functions of COX-1 and COX-2, Prostaglandins & Other Lipid Mediators, 6869, 165, 10.1016/S0090-6980(02)00029-1 Mrak, 2001, The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease, Neurobiology of Aging, 22, 915, 10.1016/S0197-4580(01)00293-7 Mrak, 2001, Interleukin-1, neuroinflammation, and Alzheimer's disease, Neurobiology of Aging, 22, 903, 10.1016/S0197-4580(01)00287-1 Nagele, 2003, Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer's disease brains, Brain Research, 971, 197, 10.1016/S0006-8993(03)02361-8 Netland, 1998, Indomethacin reverses the microglial response to amyloid β-protein, Neurobiology of Aging, 19, 201, 10.1016/S0197-4580(98)00047-5 Nicoll, 2000, Association of interleukin-1 gene polymorphisms with Alzheimer's disease, Annals of Neurology, 47, 365, 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G Nilsson, 2001, Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of alpha1-antichymotrypsin in astrocytes: significance for Alzheimer's disease, Neurochemistry International, 39, 361, 10.1016/S0197-0186(01)00043-2 Nogawa, 2003, COX-2 expression in brains of patients with familial Alzheimer's disease, International Congress Series, 1252, 363, 10.1016/S0531-5131(03)00076-1 Papassotiropoulos, 1999, A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk of sporadic Alzheimer's disease, Annals of Neurology, 45, 666, 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3 Papassotiropoulos, 2001, Genetics of interleukin 6: implications for Alzheimer's disease, Neurobiology of Aging, 22, 863, 10.1016/S0197-4580(01)00294-9 Pasinetti, 2002, From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia, Journal of Alzheimer's Disease, 4, 435, 10.3233/JAD-2002-4510 Pasinetti, 1998, Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain, Neuroscience, 87, 319, 10.1016/S0306-4522(98)00218-8 Pasternack, 1989, Astrocytes in Alzheimer's disease gray matter express alpha1-antichymotrypsin mRNA, American Journal of Pathology, 125, 827 Perea, 2002, Communication between astrocytes and neurons: a complex language, Journal of Physiology – Paris, 96, 199, 10.1016/S0928-4257(02)00007-4 Perry, 2001, The role of TNF and its receptors in Alzheimer's disease, Neurobiology of Aging, 22, 873, 10.1016/S0197-4580(01)00291-3 Peskind, 2001, Increased CSF cortisol in AD is a function of APOE genotype, Neurology, 56, 1094, 10.1212/WNL.56.8.1094 Price, 2002, Activation of complement cascade, and lack of regulatory proteins, on plaques and tangles in aging and early Alzheimer's disease, Neurobiology of Aging, 23, 223 Qiu, 1997, Degradation of amyloid β-protein by a metalloprotease secreted by microglia and other neural and non-neural cells, Journal of Biological Chemistry, 272, 6641, 10.1074/jbc.272.10.6641 Qiu, 1998, Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation, Journal of Biological Chemistry, 273, 32730, 10.1074/jbc.273.49.32730 Reines, 2004, Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study, Neurology, 62, 66, 10.1212/WNL.62.1.66 Renauld, 2002, Tumor necrosis factor expressed by primary hippocampal neurons SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation, Journal of Neuroscience Research, 67, 264, 10.1002/jnr.10101 Rich, 1995, Nonsteroidal anti-inflammatory drugs in Alzheimer's disease, Neurology, 45, 51, 10.1212/WNL.45.1.51 Rogers, 2001, Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease, Neurochemistry International, 39, 333, 10.1016/S0197-0186(01)00040-7 Rogers, 1992, Complement activation by β-amyloid in Alzheimer's disease, Proceedings of the National Academy of Sciences USA, 89, 10016, 10.1073/pnas.89.21.10016 Rogers, 2001, Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells, Glia, 33, 306, 10.1002/1098-1136(20010315)33:4<306::AID-GLIA1029>3.0.CO;2-W Rogers, 2002, Microglia and inflammatory mechanisms in the clearance of amyloid β peptide, Glia, 40, 260, 10.1002/glia.10153 Sastre, 2003, Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase, Journal of Neurosciences, 23, 9796, 10.1523/JNEUROSCI.23-30-09796.2003 Sciacca, 2003, Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease, Neurobiology of Aging, 24, 927, 10.1016/S0197-4580(03)00011-3 Sharma, 2001, Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores, Proceedings of the National Academy of Sciences USA, 98, 4148, 10.1073/pnas.071540198 Sharma, 2002, Nicotinic receptor signaling in nonexcitable cells, Journal of Neurobiology, 53, 524, 10.1002/neu.10114 Schug, 2003, Opioid and non-opioid analgesics, Best Practice & Research: Clinical Anaesthesiology, 17, 91, 10.1053/bean.2003.0267 Shen, 1997, Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer disease, Brain Research, 769, 391, 10.1016/S0006-8993(97)00850-0 Shen, 2001, Complement activation by neurofibrillary tangles in Alzheimer's disease, Neuroscience Letters, 305, 165, 10.1016/S0304-3940(01)01842-0 Sheng, 1997, Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha + microglia and S100beta + astrocytes with neurofibrillary tangles stages, Journal of Neuropathology and Experimental Neurology, 56, 285, 10.1097/00005072-199703000-00007 Sherwin, 2003, Estrogen and cognitive functioning in women, Endocrine Reviews, 24, 133, 10.1210/er.2001-0016 Shibata, 2002, Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases, American Journal of Medical Genetics, 114, 136, 10.1002/ajmg.10417 Simic, 2000, nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease, Experimental Neurology, 165, 12, 10.1006/exnr.2000.7448 Skovronsky, 2001, Amyloid precursor protein and amyloid beta peptide in human platelets: role of cyclooxygenase and protein kinase C, Journal of Biological Chemistry, 276, 17034, 10.1074/jbc.M006285200 Smit, 2001, A glia-derived acetylcholine-binding protein that modulates synaptic transmission, Nature, 411, 261, 10.1038/35077000 Smits, 2002, Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes, Journal of Neuroimmunology, 127, 160, 10.1016/S0165-5728(02)00112-1 Stoll, 2000, Cytokines in CNS disorders: neurotoxicity versus neuroprotection, Journal of Neural Transmission – Supplement, 59, 81 Streit, 1995, The brain's immune system, Scientific American, 273, 38, 10.1038/scientificamerican1195-54 Streit, 1999, Reactive microgliosis, Progress in Neurobiology, 57, 563, 10.1016/S0301-0082(98)00069-0 Streit, 2001, Chemokines and Alzheimer's disease, Neurobiology of Aging, 22, 909, 10.1016/S0197-4580(01)00290-1 Strohmeyer, 2000, Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain, Molecular Brain Research, 81, 7, 10.1016/S0169-328X(00)00149-2 Szalai, 1997, C-reactive Protein: structural biology, gene expression and host defense function, Immunologic Research, 16, 127, 10.1007/BF02786357 Szczepanik, 2003, IL-10 and glucocorticoids inhibit Abeta(1–42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system, Journal of Alzheimer's Disease, 5, 105, 10.3233/JAD-2003-5205 Szczepanik, 2001, Amyloid-β peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo, Journal of Neurochemistry, 77, 304, 10.1046/j.1471-4159.2001.t01-1-00240.x Tarkowski, 2003, Cerebral pattern of pro- and anti-inflammatory cytokines in dementias., Brain Research Bulletin, 61, 255, 10.1016/S0361-9230(03)00088-1 Tchelingerian, 1994, TNF alpha gene expression is induced in neurons after a hippocampal lesion, Neuroreport, 5, 585, 10.1097/00001756-199401000-00013 Tchelingerian, 1996, Identification and topography of neuronal cells populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion, Journal of Neuroscience Research, 43, 99, 10.1002/jnr.490430113 Teaktong, 2003, Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes, Glia, 41, 207, 10.1002/glia.10132 Terai, 1997, Neurons express proteins of the classical complement pathway in Alzheimer disease, Brain Research, 769, 385, 10.1016/S0006-8993(97)00849-4 Tomozawa, 1996, Apoptosis of cultured microglia by the deprivation of macrophage colony stimulating factor, Neuroscience Research, 25, 7, 10.1016/0168-0102(96)01021-8 Valeria, 1998, The role of C/EBP isoforms in the control of inflammatory and native immunity functions, Journal of Biological Chemistry, 273, 29279, 10.1074/jbc.273.45.29279 Van Gool, 2001, Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study, Lancet, 358, 455, 10.1016/S0140-6736(01)05623-9 Wang, 2000, β-Amyloid1–42 binds to α7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer's disease pathology, Journal of Biological Chemistry, 275, 5626, 10.1074/jbc.275.8.5626 Wang, 2003, Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation, Nature, 421, 384, 10.1038/nature01339 Webster, 1997, Aggregation state-dependent activation of the classical component pathway by the amyloid beta peptide, Journal of Neurochemistry, 69, 388, 10.1046/j.1471-4159.1997.69010388.x Webster, 1997, Molecular and cellular characterization of the membrane attack complex, c5b-9, in Alzheimer's disease, Neurobiology of Aging, 18, 415, 10.1016/S0197-4580(97)00042-0 Weggen, 2001, A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity, Nature, 414, 212, 10.1038/35102591 Weggen, 2003, Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity, Journal of Biological Chemistry, 278, 31831, 10.1074/jbc.M303592200 Wegiel, 2000, Microglial cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation, Acta Neuropathologica, 100, 356, 10.1007/s004010000199 Weldon, 1998, Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo, Journal of Neuroscience, 18, 2161, 10.1523/JNEUROSCI.18-06-02161.1998 Wessler, 1997, Mammalian glial cells in culture synthesize acetylcholine, Naunyn-Schmiedeberg's Archives of Pharmacology, 356, 694, 10.1007/PL00005107 Wilson, 2002, Cytokines and cognition-the case for a head-to-toe inflammation paradigm, Journal of the American Geriatric Society, 50, 2041, 10.1046/j.1532-5415.2002.50619.x Wyss-Coray, 2003, Adult mouse astrocytes degrade amyloid-β in vitro and in situ, Nature Medicine, 9, 453, 10.1038/nm838 Yamaguchi, 1998, Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques, Acta Neuropathologica, 95, 217, 10.1007/s004010050790 Yan, 2003, Anti-inflammatory drug therapy alters β-amyloid processing and deposition in an animal model of Alzheimer's disease, Journal of Neuroscience, 23, 7504, 10.1523/JNEUROSCI.23-20-07504.2003 Yang, 2002, Complement protective protein XD59 is deficient in brains with neurodegenerative disorder, Neurobiology of Aging, 23, 223 Yasojima, 1999, Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer's disease, Brain Research, 833, 297, 10.1016/S0006-8993(99)01514-0 Yasojima, 1999, Up-regulation and activation of the complement system in the Alzheimer's disease brain, American Journal of Pathology, 154, 927, 10.1016/S0002-9440(10)65340-0 Yasojima, 1999, Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNA and proteins in human brain and peripheral organs, Brain Research, 830, 226, 10.1016/S0006-8993(99)01389-X Yasojima, 2000, Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease, Brain Research, 887, 80, 10.1016/S0006-8993(00)02970-X Yu, 2002, Constitutive expression of proinflammatory complement components by subsets of neurons in the central nervous system, Journal of Neuroimmunology, 123, 91, 10.1016/S0165-5728(01)00483-0 Zamani, 2001, Nicotine and its interaction with β-amyloid protein: a short review, Biological Psychiatry, 49, 221, 10.1016/S0006-3223(00)01108-2 Zandi, 2001, Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence, Neurobiology of Aging, 22, 811, 10.1016/S0197-4580(01)00297-4 Zhou, 2003, Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Aβ42 by inhibiting Rho, Science, 302, 1215, 10.1126/science.1090154